Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-03-13
1997-05-13
Bleutge, John C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 514263, 536 276, 536 2613, C07H 1916, C07H 19167
Patent
active
056292988
ABSTRACT:
Disclosed are methods of increasing the contractile performance of a compromised myocardium in a mammal. The methods include administering a therapeutically affective amount of an adenosine A.sub.2 receptor agonist. Also disclosed are methods that include administering in conjunction with an adenosine A.sub.2 receptor agonist a second compound which potentiates the beneficial effect of the adenosine A.sub.2 receptor agonist, e.g., an adenosine transport inhibitor, an inhibitor of adenosine metabolism or an adenosine A.sub.1 receptor antagonist.
REFERENCES:
patent: 4673563 (1987-06-01), Berne et al.
patent: 4880783 (1989-11-01), Mentzer, Jr. et al.
patent: 5047534 (1991-09-01), Peet et al.
patent: 5075290 (1991-12-01), Findley et al.
patent: 5206222 (1993-04-01), Forman et al.
patent: 5231086 (1993-07-01), Sollevi
patent: 5236908 (1993-08-01), Gruber et al.
Feldman MD, et al., "Pharmacologic Evidence That Deficient Production of Cyclic Adenoisine Monophosphate May Be The Primary Cause of Contractile Dysfunction in End-Stage Heart Failure", 43rd Annual Meeting of the American Federation for Clinical Research, Washington, D.C., held May 2-5, 1986, Clinical Research, vol. 34, No. 2, Issued 1986. 297A (Abstract Only).
Takeo et al., "Adenine Nucleotide Metabolites are Beneficial for Recovery of Cardiac Contractile Force After Hypoxia", J. of Molecular & Cellular Cardiology, 20 (3), Issued Mar. 1988, pp. 187-199 (abstract).
Belardinelli et al., "The cardiac effects of adenoisine," Progress Cardiovasc. Disease 32:73-97 (1989).
Belardinelli et al., "Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes," Circ. Res. 53:287-297 (1983).
Dobson et al., "The antiadrenergic actions of adenosine in the heart," In: Topics and Perspectives in Adenosine Research, Gerlach, E., Becker, B. F. (eds), Springer-Verlag, Berlin pp. 356-368 (1987).
Dobson et al., "Increased myocardial adenosine production and reduction of .beta.-adrenergic contractile response in aged hearts," Circ. Res. 66:1381-1390 (1990).
Dobson, et al. "Adenosine A2-receptor agonists elicit a positive inotropic response and increase adenylyl cyclase activity in rat ventricular myocytes," Drug Develop. Res. 31:265 (abstract) (1994).
Dobson et al., "Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart," J. Mol. Cell. Cardiol. 16:813-822 (1984).
Dobson et al., "Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts," Amer. J. Physiol. 251:H455-H462 (1986).
Dobson et al., "Adenosine inhibition of .beta.-adrenergic induced responses in aged hearts," Amer. J. Physiol. 265:H494-H503 (1993).
Fedida, "Modulation of cardiac contractility by .alpha.1-Adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs," Circ. Res. 60:631-639 (1987).
Fenton et al., "Measurement by fluorescence of interstitial adenosine levels in normoxic, hypoxic, and ischemic perfused rat hearts," Circ. Res. 60:177-184 (1987).
Fenton et al., "Hypoxia enhances isoproterenol-induced increase in heart interstitial adenosine, depressing .beta.-adrenergic contractile responses," Circ. Res. 72:571-578.
Fenton et al., "Effect of adenosine pretreatment on reperfusion contractile depression and arrhythmias in the low-flow ischemic .beta.-adrenergic stimulated heart," Drug Develop. Res. 31:268 (abstract) (1994).
Gerencer, et al., "Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs," Br. J. Pharmacol. 107:1048-1056.
Lai et al., "Negative dromotropism of adenosine under beta-adrenergic stimulation with isoproterenol," Amer. J. Cardiol. 70:1427-1431 (1992).
Olsson et al., "Cardiovascular Purinoceptors," Physiological. Rev. 70:761-845 (1990).
Romano et al., "Adenoosine receptor coupling of adenylate cyclase of rate ventricular myocyte membranes," Am. J. Physiol. 257:H1088-H1095 (1989).
Romano et al., "Adenosine attenuation of catecholamine-enhanced contractility of rat heart in vivo," Amer. J. Physiol. 260:H1635-H1639 (1991).
Sato et al., "Endogenous adenosine blunts .beta.-adrenoceptor-mediated inotropic response in hypoperfused canine myocardium," Circulation 85:1594-1603 (1992).
Wilken et al., "Evidence against the presence of A2 adenosine receptors on guinea pig ventricular myocytes," Eur. J. Pharmacol. 192:161-163 (1991).
Xu, et al., "Expression and pharmacological characterization of a stimulatory subtype of adenosine receptor in fetal chick ventricular myocytes," Circ. Res. 70:56-65 (1992).
Zucchi, et al., "Cardiac A2 adenosine receptors--influence of ischemia," Cardiovasc. Res. 26:549-554 (1992).
Liang et al., "Adensine A.sub.2a and A.sub.2b Receptors in Cultured Fetal Chick Heart Cells," Circulation Res. 76:242-251 (1995).
Bleutge John C.
Harrison Robert H.
University of Massachusetts Medical Center
LandOfFree
Adenosine as a positive inotrop in the compromised heart does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine as a positive inotrop in the compromised heart, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine as a positive inotrop in the compromised heart will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385464